The following passage is from an interview given by Nigel Farage, the leader of the UK Independence party, to Newsweek. It triggered a fierce response from both those who oppose Farage’s stance on immigration and healthcare, but also from those who supports it, revealing the depth of the
In part 1 I put forward some reflexions triggered by my reading of Lord Fowlers’ new book AIDS Don’t Die of Prejudice and ended with a somewhat depressing view on our ability to quell the HIV epidemic without a major shift in how we respond to
The New York Times started a debate on Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection by asking five prominent researchers and HIV advocates to discuss whether promoting the use of antiviral drugs was a good public health strategy, or if it will encourage more
The participation and contribution of healthy human volunteers in clinical research is key to the successful development of new approaches to HIV prevention. But what is a “healthy volunteer”? The successful development of a HIV vaccine or of a New HIV Prevention Technology (NPT, such
Home testing and home sampling are not one and the same and it is important for potential users and their providers to understand the key differences between the two. HIV home testing is coming. Not right now, because none of the non-clinical commercial testing kits